FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $3.34B
1-Year Est. Return 92.56%
This Quarter Est. Return
1 Year Est. Return
+92.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.41B
AUM Growth
-$85.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
55
New
Increased
Reduced
Closed

Top Buys

1
+$78.7M
2
+$14.8M
3
+$13.5M
4
KALV icon
KalVista Pharmaceuticals
KALV
+$10.2M
5
PVLA
Palvella Therapeutics
PVLA
+$7.66M

Top Sells

1
+$41.7M
2
+$31.3M
3
+$30.6M
4
PCVX icon
Vaxcyte
PCVX
+$27.8M
5
TYRA icon
Tyra Biosciences
TYRA
+$17.2M

Sector Composition

1 Healthcare 99.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$18.6M 0.77%
1,479,025
-6,605
27
$18.4M 0.76%
133,333
28
$17.8M 0.74%
5,097,779
29
$17.3M 0.72%
601,129
+25,000
30
$15.7M 0.65%
373,100
31
$15.3M 0.63%
2,147,911
+793,200
32
$14.8M 0.61%
+1,120,803
33
$12.1M 0.5%
1,953,547
+61,000
34
$11.3M 0.47%
583,327
+106,000
35
$10.9M 0.45%
4,623,324
36
$10.3M 0.43%
3,175,665
+164,938
37
$8.74M 0.36%
689,655
38
$8.63M 0.36%
470,338
39
$7.9M 0.33%
1,148,591
40
$7.85M 0.33%
653,892
+637,950
41
$7.82M 0.32%
1,000,000
42
$7.31M 0.3%
936,576
43
$7.13M 0.3%
500,333
44
$6.29M 0.26%
955,515
-295,271
45
$6.11M 0.25%
2,867,750
46
$5.47M 0.23%
285,331
47
$4.99M 0.21%
1,069,244
48
$4.85M 0.2%
+1,176,735
49
$3.37M 0.14%
5,993,579
50
$3.21M 0.13%
108,762
1
2
3